In this episode of Market Foolery, Chris Hill chats with Motley Fool analyst Emily Flippen about the latest headlines and earnings reports from Wall Street. Moderna (NASDAQ: MRNA) enters a new phase in its COVID-19 vaccine trials. A popular toymaker's stock gets a steep cut. Finally, the hosts answer some listener questions about portfolio allocation and retail investment in a post-COVID-19 world.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Source Fool.com